维普中文期刊产品整合服务
24篇 您的检索式:作者名="Tremblay JM"
    题名 作者 年代 出处 被引量
1A novel mechanismfor TNFR-associated factor 6-dependent CD40 signaling 显示文摘Rowland SL Tremblay MM Ellison JM 2007J Immunol2007,179,7:1
2Negative energy balance with exercise in identical twins: plasma glucose and insulin responses 显示文摘Oppert JM Nadeau Am Tremblay A 1997Am J Physiol1997,272,:1
3Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘Strizki JM Tremblay C Xu S 2005Antimierob Agents Chemother2005,49,12:1
4The major genetic determinants of HIV-1control affect HLA class I peptide presentation显示文摘International HIV Controllers Study Pereyra F Jia X McLaren P J Telenti A de Bakker P I Walker B D Ripke S Brumme C J Pulit S L Carrington M Kadie C M Carlson J M Heckerman D Graham R R Plenge R M Deeks S G Gianniny L Crawford G Sullivan J Gonzalez E Davies L Camargo A Moore JM Beattie N Gupta S Crenshaw A Burtt N P Guiducci C Gupta N Gao X Qi Y Yuki Y Piechocka-Trocha A Cutrell E Rosenberg R Moss K L Lemay P O'Leary J Schaefer T Verma P Toth I Block B Baker B Rothchild A Lian J Proudfoot J Alvino D M Vine S Addo M M Allen T M Altfeld M Henn M R Le Gall S Streeck H Haas D W Kuritzkes D R Robbins G K Shafer R W Gulick R M Shikuma C M Haubrich R Riddler S Sax P E Daar E S Ribaudo H J Agan B Agarwal S Ahern R L Allen B L Altidor S Altschuler E L Ambardar S Anastos K Anderson B Anderson V Andrady U Antoniskis D Bangsberg D Barbaro D Barrie W Bartczak J Barton S Basden P Basgoz N Bazner S Bellos N C Benson A M Berger J Bernard N F Bernard A M Birch C Bodner S J Bolan R K Boudreaux E T Bradley M Braun J F Brndjar J E Brown S J Brown K Brown S T Burack J Bush LM Cafaro V Campbell O Campbell J Carlson R H Carmichael J K Casey K K Cavacuiti C Celestin G Chambers S T Chez N Chirch L M Cimoch P J Cohen D Cohn LE Conway B Cooper D A Cornelson B Cox D T Cristofano M V Cuchural G Jr Czartoski J L Dahman J M Daly J S Davis B T Davis K Davod S M DeJesus E Dietz C A Dunham E Dunn M E Ellerin T B Eron J J Fangman J J Farel C E Ferlazzo H Fidler S Fleenor-Ford A Frankel R Freedberg K A French N K Fuchs JD Fuller J D Gaberman J Gallant J E Gandhi R T Garcia E Garmon D Gathe J C Jr Gaultier C R Gebre W Gilman F D Gilson I Goepfert P A Gottlieb M S Goulston C Groger R K Gurley T D Haber S Hardwicke R Hardy W D Harrigan P R Hawkins T N Heath S Hecht F M Henry W K Hladek M Hoffman R P Horton J M Hsu R K Huhn G D Hunt P Hupert M J Illeman M L Jaeger H Jellinger R M John M Johnson J A Johnson K L Johnson H Johnson K Joly J Jordan W C Kauffman C A Khanlou H Killian R K Kim A Y Kim D D Kinder C A Kirchner J T Kogelman L Kojic E M Korthuis P T Kurisu W Kwon D S LaMar M Lampiris H Lanzafame M Lederman M M Lee D M Lee J M Lee M J Lee E T Lemoine J Levy J A Llibre J M Liguori M A Little S J Liu A Y Lopez A J Loutfy M R Loy D Mohammed D Y Man A Mansour M K Marconi V C Markowitz M Marques R Martin J N Martin H L Jr Mayer K H McElrath M J McGhee T A McGovern B H McGowan K McIntyre D Mcleod GX Menezes P Mesa G Metroka CE Meyer-Olson D Miller A O Montgomery K Mounzer K C Nagami E H Nagin I Nahass R G Nelson M O Nielsen C Norene D L O'Connor D H Ojikutu B O Okulicz J Oladehin O O Oldfield E C Olender S A Ostrowski M Owen WF Jr Pae E Parsonnet J Pavlatos A M Perlmutter A M Pierce M N Pincus J M Pisani L Price L J Proia L Prokesch R C Pujet H C Ramgopal M Rathod A Rausch M Ravishankar J Rhame F S Richards C S Richman D D Rodes B Rodriguez M Rose R C 3rd Rosenberg E S Rosenthal D Ross P E Rubin D S Rumbaugh E Saenz L Salvaggio M R Sanchez WC Sanjana V M Santiago S Schmidt W Schuitemaker H Sestak P M Shalit P Shay W Shirvani V N Silebi V I Sizemore J M Jr Skolnik P R Sokol-Anderson M Sosman J M Stabile P Stapleton J T Starrett S Stein F Stellbrink H J Sterman FL Stone V E Stone D R Tambussi G Taplitz R A Tedaldi E M Telenti A Theisen W Torres R Tosiello L Tremblay C Tribble M A Trinh P D Tsao A Ueda P Vaccaro A Valadas E Vanig T J Vecino I Vega V M Veikley W Wade B H Walworth C Wanidworanun C Ward D J Warner D A Weber R D Webster D Weis S Wheeler D A White D J Wilkins E Winston A Wlodaver C G van't Wout A Wright D P Yang O O Yurdin D L Zabukovic B W Zachary K C Zeeman B Zhao M 2010Science2010,330,6010:1
5Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations显示文摘 Bergeron J Gagne JM 2005Metabolism2005,54,8:1
6Discovery and characterization of vicriviroc (SCH 417690),a CCR5 antagonist with potent activity against human immunodeficiency virus type 1显示文摘Strizki JM Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,12:1
7Discovery and charac- terization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘Strizki JM Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,:1
8Relation between therapeu- tic orientation and personality in psychotherapists 显示文摘Tremblay JM Herron WG Schultz CL 1986Prof Psychol Res Pract1986,17,2:1
9Camelid single domain antibodies (VHHs) as neuronal cell intrabody binding agents and inhibitors of Clostridium botulinum neurotoxin (BoNT) proteases显示文摘Tremblay JM Kuo CL Abeijon C 2010Toxicon2010,56,6:1
10Discovery and characterization of vieriviroe (SCH417690), a CCR5 antagonist with potent activity against human immunodeficieney virus type 1 显示文摘Strizki JM Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,12:1
11Discovery and characterization of vicriviroc( SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘Strizki JM Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,12:1
12Functions of C-terminus Have Different Effects On the Information and Activity of Phosphatidylinositol Transfer Protein显示文摘 Tremblay JM Yarborough LR 1996Biochemistry1996,35,12:1
13Mechanism of interaction of PITPalpha with membranes:conformational changes in the C-terminus associated with membrane binding显示文摘Tremblay JM Unruh JR Johnson CK 2005Arch Biochem Biophys2005,444,2:1
14Discovery and characteriza- tion of vieriviroc (SCH417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1显示文摘Strizki JM Tremblay C Xu S 2005Anti- microbAgents Chemother2005,49,12:1
15Discovery and characterization of vicriviroc (SCH 417690),a CCR5 antagonist with potent activity against human immunadeficiency virus type 1显示文摘 Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,12:1
16Career Plateau and Work Attitudes: An Empirical Study of Managers显示文摘Tremblay M Roger A Toulouse JM 1995Human Relations1995,48,3:1
17Discovery and characterization of vicriviroc(SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘Strizki JM Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,12:1
18Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1 显示文摘Strizki JM Tremblay C Xu S 2005Antimicrob Agents Chemother2005,49,:1
19Lakes and reservoirs as regulators of carbon cycling and climate 显示文摘Tranvik LJ Downing JA Cotner JB Loiselle SA Striegl RG Ballatore TJ Dillon P Finlay K Fortino K Knoll L Kortelainen PL Kutser T Larsen S Laurion I Leech DM Mccallister SL Mcknight DM Melack JM Overholt E Porter JA Prairie Y Renwick WH Roland F Sherman BS Schindler DW Sobek S Tremblay A Vanni MJ Verschoor AM von Wachenfeldt E Weyhenmeyer CA 2009Limnol Oceanogr2009,54,2:1
20A novel mech- anism for TNFR-associated factor 6-dependent CI)40 signal- ing 显示文摘Rowland SL Tremblay MM Ellison JM 2007J Immunol2007,179,7:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费